Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

Giovanna Rege-Cambrin, PhD, Stefano Ulisciani, MD, Giovanna Mattioli, MD, Carmen Fava, MD, Emilia Giugliano, BD, Vanessa Brunetto, BD, Enrico Gottardi, BD, Milena Fava, BD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1956.

https://doi.org/10.1182/blood.V110.11.1956.1956

Published: 2007

Journal Articles

The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance.

Daniela Cilloni, MD, Francesca Messa, PhD, Francesca Arruga, PhD, Ilaria Defilippi, PhD, Alessandro Morotti, MD, Emanuela Messa, MD, Sonia Carturan, PhD, Milena Fava, PhD, Enrico Gottardi, PhD, Giovanni Martinelli, MD, Michele Baccarani, MD, Giuseppe Saglio, MD

Blood (2004) 104 (11): 2940.

https://doi.org/10.1182/blood.V104.11.2940.2940

Published: 2004

Journal Articles

WT-1 Over-Expression Could Be Related to " High Metaplastic Index" in Myelofibrosis with Myeloid Metaplasia (MMM) Patients. A Preliminary Report.

Francesco Iuliano, MD, Daniela Cilloni, MD, Enrico Gottardi, MD, Milena Fava, MD, Flora Fabiano, MD, Antonio Peta, MD, Giuseppe Saglio, MD

Blood (2004) 104 (11): 4761.

https://doi.org/10.1182/blood.V104.11.4761.4761

Published: 2004

Journal Articles

ABL Mutations in Late-Chronic Phase Chronic Myeloid Leukemia Patients with Cytogenetic Refractoriness to Imatinib Are Associated with a Greater Likelihood of Progression to Blast Crisis and Shorter Survival. on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia.

Blood (2004) 104 (11): 1005.

https://doi.org/10.1182/blood.V104.11.1005.1005

Published: 2004

Journal Articles

Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients

Daniela Cilloni, Sonia Carturan, Enrico Gottardi, Francesca Messa, Milena Fava, Ilaria Defilippi, Francesca Arruga, Giuseppe Saglio

Blood (2004) 103 (6): 2428–2429.

https://doi.org/10.1182/blood-2003-10-3488

Published: 2004

Journal Articles

Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias

Daniela Cilloni, Sonia Carturan, Enrico Gottardi, Francesca Messa, Emanuela Messa, Milena Fava, Daniela Diverio, Angelo Guerrasio, Francesco Lo-Coco, Giuseppe Saglio

Blood (2003) 102 (7): 2705–2706.

https://doi.org/10.1182/blood-2003-07-2256

Published: 2003

Journal Articles

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection

Daniela Cilloni, Enrico Gottardi, Milena Fava, Francesca Messa, Sonia Carturan, Alessandro Busca, Angelo Guerrasio, Giuseppe Saglio

Blood (2003) 102 (2): 773–774.

https://doi.org/10.1182/blood-2003-03-0980

Published: 2003

NARROW

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance.

WT-1 Over-Expression Could Be Related to " High Metaplastic Index" in Myelofibrosis with Myeloid Metaplasia (MMM) Patients. A Preliminary Report.

ABL Mutations in Late-Chronic Phase Chronic Myeloid Leukemia Patients with Cytogenetic Refractoriness to Imatinib Are Associated with a Greater Likelihood of Progression to Blast Crisis and Shorter Survival. on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia.

Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients

Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection

Email alerts

ASH Publications

American Society of Hematology

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance.

WT-1 Over-Expression Could Be Related to " High Metaplastic Index" in Myelofibrosis with Myeloid Metaplasia (MMM) Patients. A Preliminary Report.

ABL Mutations in Late-Chronic Phase Chronic Myeloid Leukemia Patients with Cytogenetic Refractoriness to Imatinib Are Associated with a Greater Likelihood of Progression to Blast Crisis and Shorter Survival. on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia.

Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients

Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only